封面
市场调查报告书
商品编码
1449603

全球葡萄糖生物感测器市场:按技术、按应用、按最终用途、按地区

Global Glucose Biosensor Market, By Technology, By Application, By End Use, By Geography

出版日期: | 出版商: Coherent Market Insights | 英文 170 Pages | 商品交期: 2-3个工作天内

价格
简介目录

全球葡萄糖生物感测器市场规模预计将从2023年的117.7亿美元增加到2031年的213亿美元,预测期间(2024-2031年)的年复合成长率(CAGR)为7.7%。

报告范围 报告详情
基准年 2023年 2023/2024年市场规模 117.7亿美元
实际资料 2019-2023 预测期 2024-2031
预测期间 2023/2024 至 2030/2031 年复合年增长率: 7.70% 2030/2031价值预测 213亿美元
图 1. 2024 年葡萄糖生物感测器的全球市场占有率(%)(按地区)
全球葡萄糖生物感测器市场-IMG1

预计全球葡萄糖生物感测器市场在预测期内将显着成长。葡萄糖生物感测器是一种用于检测生物样本中葡萄糖浓度的分析装置。它结合了生物辨识元件,例如葡萄糖氧化酵素酶和葡萄糖结合蛋白质。生物辨识元件固定在物理化学感测器上,并将生物事件转换为可量化的分析讯号。糖尿病盛行率的增加以及有关自我监测和居家照护的严格监管通讯协定是推动该市场成长的主要因素。微创、低成本、高精度和用户友好的生物感测器开发方面的技术进步正在加速其在照护现场和家庭应用中的采用。

市场动态:

全球葡萄糖生物感测器市场的成长是由老年人口的增加和全球糖尿病盛行率的增加所推动的。根据国际糖尿病联盟的数据,2019 年约有 4.63 亿成年人(20 至 79 岁)患有糖尿病,预计到 2045 年将增加至 7 亿。这导致自我监测血糖的需求显着增加。此外,有利的报销政策和政府促进血糖自我监测的措施正在推动市场成长。然而,严格的监管核准和与生物感测器相关的高成本预计将在预测期内在一定程度上阻碍市场扩张。从积极的一面来看,穿戴式、非侵入式、智慧型手机整合生物感测器的研发正在取得进展,开闢了新的途径。

本研究的主要特点

  • 该报告对全球葡萄糖生物感测器市场进行了详细分析,并提供了以2023年为基准年的预测期(2024-2031)的市场规模和年复合成长率(CAGR%)。
  • 它阐明了各个细分市场的潜在收益成长机会,并解释了该市场有吸引力的投资提案矩阵。
  • 它还提供了有关市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景、主要企业采取的竞争策略等的主要考察。
  • 它根据公司亮点、产品系列、主要亮点、绩效和策略等参数,介绍了全球葡萄糖生物感测器市场的主要企业。
  • 该报告的见解将使行销人员和经营团队能够就未来的产品发布、类型升级、市场扩张和行销策略负责人明智的决策。
  • 全球葡萄糖生物感测器市场报告针对该行业的各个相关人员,如投资者、供应商、产品製造商、经销商、新进业者和财务分析师。
  • 相关人员可以透过用于分析全球葡萄糖生物感测器市场的各种策略矩阵来促进他们的决策。

目录

第一章 研究目的与前提

  • 研究目标
  • 先决条件
  • 简称

第二章 市场展望

  • 报告说明
    • 市场定义和范围
  • 执行摘要
  • Coherent Opportunity Map(COM)

第三章市场动态、法规及趋势分析

  • 市场动态
    • 糖尿病盛行率上升
    • 老年人口增加
    • 严格的监理政策
  • 主要亮点
  • 监管场景
  • 最近的趋势
  • PEST分析
  • 波特的分析
  • 产品发表会
  • 合併、收购和合作

第四章全球葡萄糖生物感测器市场—冠状病毒 (COVID-19) 大流行的影响

  • 新型冠状病毒感染疾病(COVID-19)的流行病学
  • 供需面分析
  • 经济影响

第 5 章全球葡萄糖生物感测器市场(按技术),2019-2031

  • 酵素生物感测器
  • 非酵素生物感测器

第六章全球葡萄糖生物感测器市场,依应用分类,2019-2031

  • 家庭诊断
  • 医院和诊所
  • 研究与开发

第 7 章全球葡萄糖生物感测器市场,按最终用户划分,2019-2031 年

  • 医院
  • 居家护理
  • 诊断中心

第8章全球葡萄糖生物感测器市场,按地区,2019-2031

  • 北美洲
  • 美国
  • 加拿大
  • 欧洲
  • 德国
  • 英国
  • 西班牙
  • 法国
  • 义大利
  • 俄罗斯
  • 欧洲其他地区
  • 亚太地区
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国
  • ASEAN
  • 其他亚太地区
  • 拉丁美洲
  • 巴西
  • 阿根廷
  • 墨西哥
  • 其他拉丁美洲
  • 中东
  • 海湾合作委员会国家
  • 以色列
  • 其他中东地区
  • 非洲
  • 北非
  • 中部非洲
  • 南非

第9章 竞争格局

  • 公司简介
    • Abbott Laboratories
    • Dexcom
    • Ascenia Diabetes Car Company Highlights
    • Nova Diabetes Care
    • F.Hoffmann-La Roche Ltd.
    • Sanofi
    • GlySens Incorporated
    • Trividia Health
    • Bayer
    • Lifescan

第10章

  • 参考
  • 调查方法
  • 关于出版商
简介目录
Product Code: CMI6631

The global glucose biosensor market size is expected to reach US$ 21.3 Bn by 2031 from US$ 11.77 Bn in 2023, exhibiting a compound annual growth rate (CAGR) of 7.7% during the forecast period (2024-2031).

Report Coverage Report Details
Base Year: 2023 Market Size in 2023/2024: US$ 11.77 Bn
Historical Data for: 2019 to 2023 Forecast Period: 2024 - 2031
Forecast Period 2023/2024 to 2030/2031 CAGR: 7.70% 2030/2031 Value Projection: US$ 21.3 Bn
Figure 1. Global Glucose Biosensor Market Share (%), By Region, 2024
Global Glucose Biosensor Market - IMG1

The global glucose biosensor market is poised to grow at a significant rate over the forecast period. A glucose biosensor is an analytical device used for the detection of glucose concentration in biological samples. It incorporates a bio-recognition element like glucose oxidase enzyme or glucose-binding protein. The bio-recognition element is immobilized on a physicochemical transducer that transforms the biological event into a quantifiable analytical signal. Increased prevalence of diabetes and stringent regulatory protocols related to self-monitoring and homecare are the key factors driving the growth of this market. Technological advancements in developing minimally invasive, low-cost, accurate, and user-friendly biosensor have accelerated their adoption in point-of-care and home-use applications.

Market Dynamics:

The growth of the global glucose biosensor market is driven by rising geriatric population and increasing incidence of diabetes across the world. As per the International Diabetes Federation, around 463 million adults (20-79 years) were living with diabetes in 2019 and the number is projected to increase to 700 million by 2045. This has significantly increased the demand for self-monitoring of blood glucose. Moreover, favorable reimbursement policies and government initiatives to promote self-monitoring are providing impetus to the market growth. However, stringent regulatory approvals and high costs associated with biosensor are expected to hinder the market expansion to some extent during the forecast period. On the positive side, ongoing R&D to develop wearable, non-invasive, and smartphone integrated biosensor opens new avenues.

Key Features of the Study:

  • This report provides an in-depth analysis of the global glucose biosensor market, and provides market size (US$ Bn) and compound annual growth rate (CAGR %) for the forecast period (2024-2031), considering 2023 as the base year.
  • It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market.
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players.
  • It profiles key players in the global glucose biosensor market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
  • Key companies covered as a part of this study include Abbott Laboratories, Dexcom, Ascenia Diabetes Care, Nova Diabetes Care, F. Hoffmann-La Roche Ltd., Sanofi, GlySens Incorporated, Trividia Health, Bayer, and Lifescan.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
  • The global glucose biosensor market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global glucose biosensor market.

Detailed Segmentation:

  • Global Glucose Biosensor Market, By Technology
    • Enzymatic Biosensor
    • Non-Enzymatic Biosensor
  • Global Glucose Biosensor Market, By Application
    • Home Diagnostics
    • Hospitals and Clinics
    • Research and Development
  • Global Glucose Biosensor Market, By End Use
    • Hospitals
    • Homecare
    • Diagnostic centers
  • Global Glucose Biosensor Market, By Region
    • North America
    • Latin America
    • Europe
    • Asia Pacific
    • Middle East
    • Africa
  • Top Companies in the Global Glucose Biosensor Market:
    • Abbott Laboratories
    • Dexcom
    • Ascenia Diabetes Care
    • Nova Diabetes Care
    • Hoffmann-La Roche Ltd.
    • Sanofi
    • GlySens Incorporated
    • Trividia Health
    • Bayer
    • Lifescan

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet, By Technology
    • Market Snippet, By Application
    • Market Snippet, By End User
    • Market Snippet, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Rising prevalence of diabetes
    • Growing geriatric population
    • Stringent regulatory policies
  • Key Highlights
  • Regulatory Scenario
  • Recent Trends
  • PEST Analysis
  • PORTER's Analysis
  • Product Launches
  • Mergers, Acquisitions, and Collaborations

4. Global Glucose Biosensor Market - Impact of Coronavirus (COVID-19) Pandemic

  • COVID-19 Epidemiology
  • Supply Side and Demand Side Analysis
  • Economic Impact

5. Global Glucose Biosensor Market, By Technology, 2019-2031, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, 2020 - 2031
    • Segment Trends
  • Enzymatic Biosensors
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
  • Non-Enzymatic Biosensors
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)

6. Global Glucose Biosensor Market, By Application, 2019-2031, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, 2020 - 2031
    • Segment Trends
  • Home Diagnostics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
  • Hospitals and Clinics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
  • Research and Development
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)

7. Global Glucose Biosensor Market, By End User, 2019-2031, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, 2020 - 2031
    • Segment Trends
  • Hospitals
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
  • Homecare
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
  • Diagnostic centers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)

8. Global Glucose Biosensor Market, By Region, 2019-2031, (US$ Bn)

  • Introduction
    • Market Share Analysis, By Region, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, For Region, 2020 -2031
    • Country Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2019-2031,(US$
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2019-2031,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019-2031,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019-2031,(US$ Bn)
  • U.S.
  • Canada
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2019-2031,(US$
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2019-2031,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019-2031,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019-2031,(US$ Bn)
  • Germany
  • U.K.
  • Spain
  • France
  • Italy
  • Russia
  • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2019-2031,(US$
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2019-2031,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019-2031,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019-2031,(US$ Bn)
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2019-2031,(US$
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2019-2031,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019-2031,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019-2031,(US$ Bn)
  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2019-2031,(US$
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2019-2031,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019-2031,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019-2031,(US$ Bn)
  • GCC Countries
  • Israel
  • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2019-2031,(US$
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2019-2031,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019-2031,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2019-2031,(US$ Bn)
  • North Africa
  • Central Africa
  • South Africa

9. Competitive Landscape

  • Company Profile
    • Abbott Laboratories
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
    • Dexcom
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
    • Ascenia Diabetes Car Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
    • Nova Diabetes Care
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
    • F.Hoffmann-La Roche Ltd.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
    • Sanofi
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
    • GlySens Incorporated
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
    • Trividia Health
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
    • Bayer
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
    • Lifescan
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
  • Analyst Views

10. Section

  • References
  • Research Methodology
  • About us